Table 4 Follow-up information after discharge
Variables | N = 6 | N = 4 (survival) |
|---|---|---|
Long-term survival (n, %) | 4 (66.67 %) | - |
Bed-ridden status (n, %) | 1 (16.67 %) | 1(25.00 %) |
Heart function | ||
NYHA Class II | 2(33.33 %) | 1(25.00 %) |
NYHA Class III | 4(66.67 %) | 3(75.00 %) |
Respiratory dysfunction | 2 (33.33 %) | 0(0.00 %) |
Renal dysfunction | 1 (16.67 %) | 1(25.00 %) |
Liver dysfunction | 0 (0.00 %) | 0(0.00 %) |
Neurological dysfunction | 2(33.33 %) | 1(25.00 %) |
Stroke | 1 (16.67 %) | 0(0.00 %) |
Gastrointestinal bleeding | 1 (16.67 %) | 0(0.00 %) |
Antiarrhythmic drugs use | 2 (33.33 %) | 1(25.00 %) |
Warfarin use | 1 (16.67 %) | 1(25.00 %) |
Diuretic use | 2 (33.33 %) | 1(25.00 %) |
Antihypertensive agents use | 5 (83.33 %) | 3(75.00 %) |